• Objective:
  Transformation of new treatment concepts into patent protected and marketable drug candidates with phase II clinical proof-of-concept data.
  
• Selection criteria for a new concept:

• Gender-related disease
• Patentable
• Medical need
• Marketing opportunity
• Established saftey record
• Pharmaceutical formulation possible
  
• Business:
  Creation of a patent protected phase II portfolio for outlicensing to third parties for phase III development and commercialisation.
  
• Organisation:
  Pantarhei Bioscience is organised as a project management organisation outsourcing its drug development activities.